Etoposide Capsules USP-PV POSIDE

Etoposide for Injection USP Supplier

Generic Drug Name: Etoposide Capsules USP  

Brand Name: PV POSIDE

Indications and Usage:

Treatment of acute lymphocytic leukemia (ALL), refractory acute myeloid leukemia (AML), recurrent or metastatic breast cancer, central nervous system tumors, Ewing’s sarcoma, gestational trophoblastic disease, Hodgkin lymphoma, merkel cell cancer, refractory multiple myeloma, neuroblastoma, neuroendocrine tumors (adrenal gland and carcinoid tumors), non-Hodgkin lymphomas, non-small cell lung cancer (NSCLC), osteosarcoma, ovarian cancer (refractory), prostate cancer, retinoblastoma, metastatic soft tissue sarcoma, thymic malignancies (locally advanced or metastatic), unknown-primary adenocarcinoma, Wilms’ tumor; conditioning regimen for hematopoietic cell transplantation

Certification: WHO-GMP & WHO-GDP

Product Type: Finished Product

Following information is meant for: Wholesalers, Suppliers, Importers, Doctors, CROs, Hospitals, MOH Tender Supplies, NGOs and Institutional Buyers.

Description: Each Capsule contains Etoposide

Form: Capsules

Strength: 50mg & 100mg

Pack Size: 8 Capsules per pack

Pack Insert: Yes

Storage & Handling:

Store below 25°C

PV Pharma Healthcare Pvt. Ltd.  is WHO GMP/WHO GDP Certified Pharmaceutical Manufacturer & Exporter of  Etoposide  Capsules  known as PV POSIDE available in strength of 50mg & 100mg. This product is supplied for Tenders, Emergency imports, Un – licensed Medicines &  Orphan drug.

Your Name (required)

Your Email (required)

Contact Number (required)

Subject

Select Country

Your Message